HIGH SERUM LEVELS OF SOLUBLE CD25 AND SOLUBLE CD23 IN EARLY-STAGE B-CELL - CORRELATION WITH CLINICAL CHARACTERISTICS PREDICTIVE FOR PROGRESSIVE DISEASE

被引:0
|
作者
KNAUF, WU [1 ]
ZEIGMEISTER, B [1 ]
LANGENMAIER, I [1 ]
RAGHAVACHAR, A [1 ]
EMMERICH, B [1 ]
THIEL, E [1 ]
机构
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,W-1000 BERLIN 45,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A569 / A569
页数:1
相关论文
共 50 条
  • [31] SERUM LEVELS OF SOLUBLE FORMS OF T-CELL ACTIVATION ANTIGENS CD27 AND CD25 IN SYSTEMIC LUPUS-ERYTHEMATOSUS IN RELATION WITH LYMPHOCYTES COUNT AND DISEASE COURSE
    SWAAK, AJG
    HINTZEN, RQ
    HUYSEN, V
    VANDENBRINK, HG
    SMEENK, JT
    CLINICAL RHEUMATOLOGY, 1995, 14 (03) : 293 - 300
  • [32] Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression
    Molica, S
    Vitelli, G
    Levato, D
    Giannarelli, D
    Gandolfo, GM
    CANCER, 2001, 92 (04) : 713 - 719
  • [33] ANTIBODIES TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INHIBIT PROLIFERATION, BUT INCREASE PRODUCTION OF SOLUBLE CD23 IN LYMPHOBLASTOID B-CELL LINES
    HAJEER, AH
    SNOWDEN, N
    WILSON, P
    DROVER, S
    OLLIER, WE
    IMMUNOLOGY, 1993, 80 (04) : 593 - 597
  • [34] Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis
    Ismail Oguz Kara
    Berksoy Sahin
    Ramazan Gunesacar
    Advances in Therapy, 2007, 24 : 29 - 40
  • [35] Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma
    Zinzani, PL
    Baccini, C
    Zaccaria, A
    Visani, G
    Buzzi, M
    Morelli, A
    Molinari, AL
    Salvucci, M
    Bendandi, M
    Rubboli, D
    Gherlinzoni, F
    Zanchini, R
    Tura, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1996, 57 (05) : 335 - 340
  • [36] Expression of soluble CD27 and interleukins-8 and-10 in B-cell chronic lymphocytic leukemia: Correlation with disease stage and prognosis
    Kara, Ismail Oguz
    Sahin, Berksoy
    Gunesacar, Ramazan
    ADVANCES IN THERAPY, 2007, 24 (01) : 29 - 40
  • [37] INVITRO REGULATION OF B-CELL DIFFERENTIATION BY INTERLEUKIN-6 AND SOLUBLE CD23 IN SYSTEMIC LUPUS-ERYTHEMATOSUS B-CELL SUBPOPULATIONS AND ANTIGEN-INDUCED NORMAL B-CELLS
    KLASHMAN, DJ
    MARTIN, RA
    MARTINEZMAZA, O
    STEVENS, RH
    ARTHRITIS AND RHEUMATISM, 1991, 34 (03): : 276 - 286
  • [38] CORRELATION BETWEEN SOLUBLE SERUM-CD16 (SCD16) LEVELS AND DISEASE STAGE IN PATIENTS WITH MULTIPLE-MYELOMA
    MATHIOT, C
    TEILLAUD, JL
    ELMALEK, M
    MOSSERI, V
    EULLERZIEGLER, L
    DARAGON, A
    GROSBOIS, B
    MICHAUX, JL
    FACON, T
    BERNARD, JF
    DUCLOS, B
    MONCONDUIT, M
    FRIDMAN, WH
    JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (01) : 41 - 48
  • [39] SERUM LEVELS OF INTERLEUKIN-4, SOLUBLE CD23 AND IFN-GAMMA IN RELATION TO THE DEVELOPMENT OF ALLERGIC DISEASE DURING THE FIRST 18 MONTHS OF LIFE
    BORRES, MP
    EINARSSON, R
    BJORKSTEN, B
    CLINICAL AND EXPERIMENTAL ALLERGY, 1995, 25 (06): : 543 - 548
  • [40] Epidemiologic investigation of serum levels of the soluble forms of CD25, CD54 and CD58, and T cell responsiveness after stimulation via the CD2-dependent pathway in a random sample of the general population
    Becker, N
    Krause, G
    Rensch, K
    Meuer, SC
    IMMUNOBIOLOGY, 1996, 195 (01) : 47 - 60